Energy and Capital Archives

Australian LNG Exports

Written by Keith Kohl
Posted May 13, 2014

Energy and Capital editor Keith Kohl explains why Australia looking to tap into its vast shale gas reserves by 2017.

U.S. Tight Oil Reserves

Written by Keith Kohl
Posted May 12, 2014

Energy and Capital editor Keith Kohl takes a deeper look into why the Texas oil boom can't fail, and how everyday investors should approach today's oil market.

Parsley Energy Inc. Readies IPO Under Symbol NYSE: PE

Written by Brian Hicks
Posted May 12, 2014

The Permian Basin is a hotspot for domestic oil and gas production. Midland-based Parsley Energy Inc. is in the thick of it.

Dominion (NYSE: D) Poised for LNG Exports

Written by Keith Kohl
Posted May 12, 2014

Energy and Capital editor Keith Kohl reports on the latest developments on Dominion turning its Cove Point terminal into an LNG export facility.

The Coming Coal Glut

Written by Keith Kohl
Posted May 11, 2014

Energy and Capital editor Keith Kohl reports on the next major coal mine set to open and how it will affect some of the largest coal producers in the United States

Caltex Gas Workers Strike in Cambodia

Written by Brian Hicks
Posted May 11, 2014

Continuing labor unrest in Cambodia has hit Chevron's Caltex gas stations.

Frack Ban Effects

Written by Keith Kohl
Posted May 8, 2014

Energy and Capital editor explains why Range Resources is setting itself up for even more Marcellus success going forward.

The Secret Behind Big Oil Profits

Written by Keith Kohl
Posted May 8, 2014

Energy and Capital editor Keith Kohl reveals the secret behind some of the best profits inside the oil industry.

Oilfield Services a $291 billion industry by 2019

Written by Brian Hicks
Posted May 8, 2014

Oilfield services are growing at almost 12% a year, and will push up to $291 billion by 2019, according to a new report.

GasLog Partners (NYSE: GLOP) IPO Off to Strong Strart

Written by Keith Kohl
Posted May 7, 2014

Energy and Capital editor Keith Kohl reports on the latest IPO by GasLog Partners, and questions whether investors will be rewarded in the short-term.

The Last Cheap Investment

Written by Christian DeHaemer
Posted May 7, 2014

Over the past five years, emerging markets have done a whole lot of nothing. But the smart money is moving into them now...

Chelsea Therapeutics (NASDAQ: CHTP) Acquired by Lundbeck (LUN.CO)

Written by Brian Hicks
Posted May 7, 2014

Chelsea Therapeutics just received FDA approval for its drug Northera. In no time flat, the company was snatched up by a bigger pharmaceutical company.